The origin of anti-nuclear antibodies in bcl-2 transgenic mice
スポンサーリンク
概要
著者
-
Mandik‐nayak L
The Wistar Institute Department Of Medicine University Of Pennsylvania School Of Medicine
-
MANDIK-NAYAK Laura
The Wistar Institute
-
NAYAK Sudhir
The Wistar Institute Department of Medicine, University of Pennsylvania School of Medicine
-
SOKOL Caroline
The Wistar Institute Department of Medicine, University of Pennsylvania School of Medicine
-
EATON-BASSIRI Ashlyn
The Wistar Institute Department of Medicine, University of Pennsylvania School of Medicine
-
MADAIO Michael
The Wistar Institute Department of Medicine, University of Pennsylvania School of Medicine
-
CATON Andrew
The Wistar Institute Department of Medicine, University of Pennsylvania School of Medicine
-
ERIKSON Caton
The Wistar Institute Department of Medicine, University of Pennsylvania School of Medicine
-
Nayak Sudhir
The Wistar Institute Department Of Medicine University Of Pennsylvania School Of Medicine
-
Caton A
The Wistar Institute Department Of Medicine University Of Pennsylvania School Of Medicine
-
Caton Andrew
The Wistar Institute
-
Eaton-bassiri Ashlyn
The Wistar Institute
-
Eaton-bassiri Ashlyn
The Wistar Institute Department Of Medicine University Of Pennsylvania School Of Medicine
-
Erikson Caton
The Wistar Institute Department Of Medicine University Of Pennsylvania School Of Medicine
-
Madaio M
The Wistar Institute Department Of Medicine University Of Pennsylvania School Of Medicine
-
Sokol C
The Wistar Institute Department Of Medicine University Of Pennsylvania School Of Medicine
関連論文
- Characterization of anergic anti-DNA B cells: B cell anergy is a T cell-independent and potentially reversible process
- The origin of anti-nuclear antibodies in bcl-2 transgenic mice
- A major T cell determinant from the influenza virus hemagglutinin (HA) can be a cryptic self peptide in HA transgenic mice
- Alterations in splenic architecture and the localization of anti-double-stranded DNA B cells in aged mice
- Impact of effector cell differentiation on CD4+ T cells that evade negative selection by a self-peptide